Prime Medicine
PRME
83 hedge funds and large institutions have $472M invested in Prime Medicine in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 6 closing their positions.
870% more call options, than puts
Call options by funds: $97K | Put options by funds: $10K
133% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 15
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
5% more funds holding
Funds holding: 79 → 83 (+4)
3.45% more ownership
Funds ownership: 47.45% → 50.89% (+3.4%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
30% less capital invested
Capital invested by funds: $676M → $472M (-$203M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$14M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.02M |
| 3 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$7.42M |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$7.41M |
| 5 |
BlackRock
New York
|
+$5.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$5.82M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$5.77M |
| 3 |
Millennium Management
New York
|
-$3.76M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.08M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.52M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Comerica Bank
Dallas,
Texas
| $7.43K | +$10.1K | +779 | New |
|
|
CCC
77
Chelsea Counsel Company
Los Angeles,
California
| $5.72K | – | – | – |
|
78
US Bancorp
Minneapolis,
Minnesota
| $3.3K | – | – | – |
|
|
BEI
79
Benjamin Edwards Inc
Clayton,
Missouri
| $3K | – | – | – |
|
|
GBT
80
Grove Bank & Trust
Miami,
Florida
| $735 | +$1K | +77 | New |
|
|
MPWT
81
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| $239 | -$117 | -9 | -26% |
|
82
Nisa Investment Advisors
St. Louis,
Missouri
| $191 | -$169 | -13 | -39% |
|
|
83
Jane Street
New York
| – | -$5.82M | -397,004 | Closed |
|
|
84
Millennium Management
New York
| – | -$3.76M | -256,560 | Closed |
|
|
LCM
85
Laurion Capital Management
New York
| – | -$819K | -55,888 | Closed |
|
|
LCS
86
Levin Capital Strategies
New York
| – | -$293K | -20,000 | Closed |
|
87
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$180K | -12,254 | Closed |
|
|
C
88
Covestor
London,
United Kingdom
| – | -$13 | -1 | -11% |
|
PRME Hedge Fund Activity: Q3 2023 in Review
83 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Prime Medicine (PRME) for Q3 2023, worth a combined $472M — down 30% from $676M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new PRME positions and 6 closed out — a net gain of 5 holders — while 35 added to existing stakes and 15 trimmed.
The largest buyer was State Street, adding an estimated $14M. The largest seller was Jane Street, exiting entirely with an estimated $5.82M sold.
- 83 institutional investors held Prime Medicine (PRME) as of Q3 2023, up from 79 in Q2 2023.
- Funds reported $472M of Prime Medicine stock for Q3 2023, down 30% quarter-over-quarter.
- 11 funds opened new Prime Medicine positions in Q3 2023 and 6 closed out, a net change of +5 holders.
- The largest Prime Medicine buyer in Q3 2023 was State Street, an estimated $14M added.
- The largest Prime Medicine seller in Q3 2023 was Jane Street, an estimated $5.82M sold.
Based on aggregated 13F filings for Q3 2023.